Developer docs
API playgroundTry for free, no card

Search company profiles

Angiotech Pharmaceuticals

Full company profile

uuid000bips

Namestring
Angiotech Pharmaceuticals
Legal namestring
Corza Medical
Company typeenum
Private
Founded yearint
1975
Descriptiontext

Corza Medical, the successor entity to the medical technology business of Angiotech Pharmaceuticals (founded 1989 in Vancouver, BC), operates as a global medical technology company headquartered in Boulder, Colorado, with international headquarters in Switzerland and an Asia-Pacific headquarters in China. The company designs, manufactures, and distributes surgical medical devices across four product verticals: Biosurgery (notably TachoSil, a hemostatic sealing pad), Biomedical Textiles (Pearsalls-branded OEM textile products), Ophthalmology (Katena reusable surgical instruments, the SensorTek ROP Kit, and the Onatec suture portfolio), and Wound Closure (Quill barbed sutures, Express Gut, and Sharpoint sutures). Manufacturing is conducted at seven global locations, and the company maintains a commercial presence in 80+ countries.

The business model is primarily B2B hardware sales of surgical consumables and instruments to hospitals, surgical centers, and specialty clinics. Revenue is generated through field sales teams organized by product category, supplemented by e-commerce storefronts for smaller practices (Wound Closure Store, Ophthalmology Store) and a recently launched enterprise customer portal (corzaeye.com) for ophthalmology customers. Pricing is quote-based for institutional customers and not publicly disclosed. The company cites 200+ years of combined innovation heritage across its portfolio of brands.

Customer segmentation is vertical-driven: Surgical Hospitals and Medical Centers, Ophthalmology Practices, Surgical Specialists (general, orthopedic, cosmetic), and OEM Partners served through a recently launched Biomedical Textiles Innovation Lab for textile-based prototyping. End-customer evidence includes named surgeons in cosmetic facial surgery, orthopedic surgery, and optometry, with testimonials emphasizing price-quality positioning against incumbent brands such as Ethicon. The company reports approximately $500M+ in annual revenue and a workforce of 3000+ employees.

Short descriptiontext

Corza Medical is a global medical technology company selling surgical devices and consumables — biosurgery, biomedical textiles, ophthalmology, and wound closure products — to hospitals, surgical centers, and OEM partners in 80+ countries.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1,001–5,000
akta.pro rankint
HeadquartersVancouver, Canada
HQ citystring
Vancouver
HQ countrystring
Canada
HQ regionstring
North America
Markets served

Serves global market

Offices3 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
surgical medical devices, wound closure sutures, ophthalmic surgical instruments, biomedical textiles OEM, surgical hemostasis products
Industry3 codes
PRIMARYHLAHADAL
Surgical Stapling, Suturing & Hemostasis (Staplers, Clips, Sealants, Tourniquets)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAA
Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYCRAFAHAG
Medical, Dental & Lab Supply Marketplaces
Consumer Products & Retail/E-commerce & Marketplaces/Wholesale/B2B E-commerce Marketplaces
NAICS code6 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Surgical Appliance and Supplies Manufacturing339113
  • Medical Equipment and Supplies Manufacturing3391
  • Ophthalmic Goods Manufacturing339115
  • Ophthalmic Goods Merchant Wholesalers423460
  • Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers42345
SIC code3 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Ophthalmic Goods3851
  • Wholesale-Medical, Dental & Hospital Equipment & Supplies5047
Product category
Surgical Medical Devices
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Device Sales
TypeHardware Sales
Description

Sale of surgical medical devices and instruments across four product categories: Biosurgery (hemostasis and sealing), Biomedical Textiles, Ophthalmology, and Wound Closure. Revenue model is primarily one-time product sales to healthcare providers, surgical centers, and hospitals.

corza.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
Pricing details1 tier
1B2B medical device sales to healthcare providers
ModelUnit PricingBilling cadencePay-as-you-go
Notes

Quote-based pricing for institutional customers. E-commerce stores available for Wound Closure and Ophthalmology products.

corza.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 7 records shown
1TachoSil
Description

Surgical hemostatic sealants used in surgery's most critical moments

corza.com
+6 more records
Core offering1 text field

Angiotech's medical technology business, now operating as Corza Medical, manufactures and sells surgical medical devices across four product verticals: Biosurgery (TachoSil hemostatic sealants), Biomedical Textiles (Pearsalls OEM textiles), Ophthalmology (Katena instruments, SensorTek ROP Kit, Onatec sutures), and Wound Closure (Quill barbed sutures, Express Gut, Sharpoint sutures). Products are sold to hospitals, surgical centers, ophthalmology practices, and individual healthcare professionals via direct field sales, e-commerce stores, and a digital customer portal in 80+ countries.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 value
  • 1000+ students and optometrists trained through Corza's medical education support
Product overview1 text field

Corza Medical is a global medical technology company offering a unified portfolio of surgical products across four core categories: Biosurgery (hemostasis and sealing products like TachoSil), Biomedical Textiles (Pearsalls OEM products), Ophthalmology (Katena instruments, SensorTek ROP Kit, Onatec sutures), and Wound Closure (Quill barbed sutures, Express Gut, Sharpoint sutures). The company operates manufacturing across seven global locations and serves customers in 80+ countries through both direct sales and online stores.

Product and service8 records
1TachoSil
CategoryBiosurgery
Description

Biosurgical sealant pad used for hemostasis and tissue sealing during surgery, intended for hospitals, surgical centers, and surgeons in operative settings.

2Quill Barbed Sutures
CategoryWound Closure
Description

Self-anchoring barbed suture product line for wound closure in surgical procedures, used by general, orthopedic, and cosmetic surgeons.

3Katena Reusable Instruments
CategoryOphthalmology
Description

Reusable ophthalmic surgical instruments used by ophthalmologists and eye care professionals for eye surgery, with a 50-year brand heritage.

4SensorTek ROP Kit
CategoryOphthalmology
Description

First and only single-use kit with integrated lens designed for retinopathy of prematurity (ROP) exams, used by ophthalmologists, optometrists, and neonatal care teams.

5Onatec Ophthalmic Suture Portfolio
CategoryOphthalmology
Description

Expanded ophthalmic suture portfolio offering microsurgical sutures for eye surgery, targeted at ophthalmologists and microsurgeons.

6Express Gut
CategoryWound Closure
Description

Absorbable surgical suture marketed as an affordable alternative to other brands without sacrificing needle quality, used by practicing surgeons.

7Sharpoint Sutures
CategoryWound Closure
Description

Surgical sutures with quality positioned as equivalent to major brands like Ethicon, used in surgical centers by orthopedic and general surgeons.

8Pearsalls Biomedical Textiles
CategoryBiomedical Textiles
Description

Biomedical textile products supplied to OEM partners for medical device prototyping and textile-based product development.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

The dominant global sutures, wound closure, and biosurgery franchise; Sharpoint is explicitly benchmarked against Ethicon in surgeon testimonials, making this the most direct comparable for Corza's wound closure and hemostasis business.

TypeBroad incumbent
Description

Broad incumbent in surgical instruments and operating-room solutions with overlapping reach into hospitals and ambulatory surgical centers; comparable as a multi-vertical surgical device competitor with global distribution.

TypeDirect peer
Description

Large diversified medical device maker with material exposure to surgical instruments, sutures, and ophthalmic surgical products; directly competes with Corza across reusable instruments and procedural consumables.

TypeDirect peer
Description

Global medical device company with a meaningful wound closure, surgical instrumentation, and orthopedics portfolio; comparable for surgical consumables, sports medicine/orthopedic wound closure, and hospital-channel sales motion.

TypeDirect peer
Description

Specialty surgical devices and instruments company with strong presence in reusable surgical instruments and tissue technologies; comparable to Corza's Katena and TachoSil-style surgical adjacencies.

TypeDirect peer
Description

Specialty medical device company focused on general surgery, orthopedics, and ophthalmology; comparable given overlapping call points in surgical centers and ophthalmic procedural devices.

TypeBroad incumbent
Description

Large diversified surgical and medical device incumbent with hospital sales coverage that overlaps Corza's surgical-center and operating-room footprint, particularly in instruments and surgical adjacencies.

TypeDirect peer
Description

Specialist in ophthalmic surgical instruments, IOLs, and single-use eye surgery consumables; the most direct niche comparable to Corza's Katena and SensorTek ophthalmology portfolio.

TypeBroad incumbent
Description

Diversified medical device incumbent with procedural and surgical adjacencies; relevant for benchmarking a multi-vertical surgical device business with global hospital coverage.

TypeBroad incumbent
Description

Large diversified medtech incumbent with hospital channel reach and adjacent device franchises; useful as a benchmark for size, channel power, and global manufacturing footprint comparable to Corza's.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers3 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

Subsidiaries1 record

Each record includes

Name, Acquired on, Relationship type, Type, Business focus

No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors8 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A3 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Angiotech Pharmaceuticals

Surgical Medical Devicessurgicalspecialties.com

Corza Medical is a global medical technology company selling surgical devices and consumables — biosurgery, biomedical textiles, ophthalmology, and wound closure products — to hospitals, surgical centers, and OEM partners in 80+ countries.

What Angiotech Pharmaceuticals does

Corza Medical, the successor entity to the medical technology business of Angiotech Pharmaceuticals (founded 1989 in Vancouver, BC), operates as a global medical technology company headquartered in Boulder, Colorado, with international headquarters in Switzerland and an Asia-Pacific headquarters in China. The company designs, manufactures, and distributes surgical medical devices across four product verticals: Biosurgery (notably TachoSil, a hemostatic sealing pad), Biomedical Textiles (Pearsalls-branded OEM textile products), Ophthalmology (Katena reusable surgical instruments, the SensorTek ROP Kit, and the Onatec suture portfolio), and Wound Closure (Quill barbed sutures, Express Gut, and Sharpoint sutures). Manufacturing is conducted at seven global locations, and the company maintains a commercial presence in 80+ countries.

The business model is primarily B2B hardware sales of surgical consumables and instruments to hospitals, surgical centers, and specialty clinics. Revenue is generated through field sales teams organized by product category, supplemented by e-commerce storefronts for smaller practices (Wound Closure Store, Ophthalmology Store) and a recently launched enterprise customer portal (corzaeye.com) for ophthalmology customers. Pricing is quote-based for institutional customers and not publicly disclosed. The company cites 200+ years of combined innovation heritage across its portfolio of brands.

Customer segmentation is vertical-driven: Surgical Hospitals and Medical Centers, Ophthalmology Practices, Surgical Specialists (general, orthopedic, cosmetic), and OEM Partners served through a recently launched Biomedical Textiles Innovation Lab for textile-based prototyping. End-customer evidence includes named surgeons in cosmetic facial surgery, orthopedic surgery, and optometry, with testimonials emphasizing price-quality positioning against incumbent brands such as Ethicon. The company reports approximately $500M+ in annual revenue and a workforce of 3000+ employees.

Angiotech Pharmaceuticals firmographics

Firmographics
Name
Angiotech Pharmaceuticals
Legal name
Corza Medical
Website
https://surgicalspecialties.com
Company type
Private
Founded year
1975
Operating status
Operating
Headcount range
1,001–5,000 employees
Short description
Corza Medical is a global medical technology company selling surgical devices and consumables — biosurgery, biomedical textiles, ophthalmology, and wound closure products — to hospitals, surgical centers, and OEM partners in 80+ countries.
Ownership category
akta.pro rank

Angiotech Pharmaceuticals industry classification

Industry
Product category
Surgical Medical Devices
NAICS
Surgical and Medical Instrument Manufacturing (339112), Surgical Appliance and Supplies Manufacturing (339113), Medical Equipment and Supplies Manufacturing (3391), Ophthalmic Goods Manufacturing (339115), Ophthalmic Goods Merchant Wholesalers (423460), Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers (42345)
SIC
Surgical & Medical Instruments & Apparatus (3841), Ophthalmic Goods (3851), Wholesale-Medical, Dental & Hospital Equipment & Supplies (5047)
akta.pro industry
PRIMARYHLAHADAL
Surgical Stapling, Suturing & Hemostasis (Staplers, Clips, Sealants, Tourniquets)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYHLAHADAA
Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Surgical Instruments, Endoscopy & OR Equipment
SECONDARYCRAFAHAG
Medical, Dental & Lab Supply Marketplaces
Consumer Products & Retail/E-commerce & Marketplaces/Wholesale/B2B E-commerce Marketplaces

Keywords

  • Surgical medical devices
  • Wound closure sutures
  • Ophthalmic surgical instruments
  • Biomedical textiles OEM
  • Surgical hemostasis products

Where Angiotech Pharmaceuticals is headquartered

Location

Headquarters

HQ city
Vancouver
HQ country
Canada
HQ region
North America

Offices3 records

Markets served

Angiotech Pharmaceuticals business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Device Sales: Sale of surgical medical devices and instruments across four product categories: Biosurgery (hemostasis and sealing), Biomedical Textiles, Ophthalmology, and Wound Closure. Revenue model is primarily one-time product sales to healthcare providers, surgical centers, and hospitals.

Pricing tiers

ModelBillingPrice
Unit PricingPay-as-you-goB2B medical device sales to healthcare providers

Go-to-market motion1 record

Distribution channels4 records

Marketing channels6 records

Angiotech Pharmaceuticals product offering

Product offering

Core offering

Angiotech's medical technology business, now operating as Corza Medical, manufactures and sells surgical medical devices across four product verticals: Biosurgery (TachoSil hemostatic sealants), Biomedical Textiles (Pearsalls OEM textiles), Ophthalmology (Katena instruments, SensorTek ROP Kit, Onatec sutures), and Wound Closure (Quill barbed sutures, Express Gut, Sharpoint sutures). Products are sold to hospitals, surgical centers, ophthalmology practices, and individual healthcare professionals via direct field sales, e-commerce stores, and a digital customer portal in 80+ countries.

Product overview

Corza Medical is a global medical technology company offering a unified portfolio of surgical products across four core categories: Biosurgery (hemostasis and sealing products like TachoSil), Biomedical Textiles (Pearsalls OEM products), Ophthalmology (Katena instruments, SensorTek ROP Kit, Onatec sutures), and Wound Closure (Quill barbed sutures, Express Gut, Sharpoint sutures). The company operates manufacturing across seven global locations and serves customers in 80+ countries through both direct sales and online stores.

Differentiator

Problem solved

Functional benefit

Brands

  • TachoSil: Surgical hemostatic sealants used in surgery's most critical moments
  • Katena
  • Onatec
  • Quill
  • Express Gut
  • Sharpoint
  • SensorTek

Products and services

  • TachoSil Biosurgical sealant pad used for hemostasis and tissue sealing during surgery, intended for hospitals, surgical centers, and surgeons in operative settings.
  • Quill Barbed Sutures Self-anchoring barbed suture product line for wound closure in surgical procedures, used by general, orthopedic, and cosmetic surgeons.
  • Katena Reusable Instruments Reusable ophthalmic surgical instruments used by ophthalmologists and eye care professionals for eye surgery, with a 50-year brand heritage.
  • SensorTek ROP Kit First and only single-use kit with integrated lens designed for retinopathy of prematurity (ROP) exams, used by ophthalmologists, optometrists, and neonatal care teams.
  • Onatec Ophthalmic Suture Portfolio Expanded ophthalmic suture portfolio offering microsurgical sutures for eye surgery, targeted at ophthalmologists and microsurgeons.
  • Express Gut Absorbable surgical suture marketed as an affordable alternative to other brands without sacrificing needle quality, used by practicing surgeons.
  • Sharpoint Sutures Surgical sutures with quality positioned as equivalent to major brands like Ethicon, used in surgical centers by orthopedic and general surgeons.
  • Pearsalls Biomedical Textiles Biomedical textile products supplied to OEM partners for medical device prototyping and textile-based product development.

Quantifiable outcome

  • 1000+ students and optometrists trained through Corza's medical education support

Companies that use Angiotech Pharmaceuticals

Customer profile

Named customers3 records

Segments4 records

Ideal customer profiles4 records

Angiotech Pharmaceuticals technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

Angiotech Pharmaceuticals partnerships and signals

Strategic signal

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Angiotech Pharmaceuticals competitors and assessment

Company assessment

Direct peers

  • Ethicon (Johnson & Johnson MedTech): The dominant global sutures, wound closure, and biosurgery franchise; Sharpoint is explicitly benchmarked against Ethicon in surgeon testimonials, making this the most direct comparable for Corza's wound closure and hemostasis business.
  • Becton, Dickinson and Company (BD): Large diversified medical device maker with material exposure to surgical instruments, sutures, and ophthalmic surgical products; directly competes with Corza across reusable instruments and procedural consumables.
  • Smith+Nephew: Global medical device company with a meaningful wound closure, surgical instrumentation, and orthopedics portfolio; comparable for surgical consumables, sports medicine/orthopedic wound closure, and hospital-channel sales motion.
  • Integra LifeSciences: Specialty surgical devices and instruments company with strong presence in reusable surgical instruments and tissue technologies; comparable to Corza's Katena and TachoSil-style surgical adjacencies.
  • CONMED: Specialty medical device company focused on general surgery, orthopedics, and ophthalmology; comparable given overlapping call points in surgical centers and ophthalmic procedural devices.
  • BVI Medical (Beaver-Visitec International): Specialist in ophthalmic surgical instruments, IOLs, and single-use eye surgery consumables; the most direct niche comparable to Corza's Katena and SensorTek ophthalmology portfolio.

Broad incumbents

  • Medtronic: Broad incumbent in surgical instruments and operating-room solutions with overlapping reach into hospitals and ambulatory surgical centers; comparable as a multi-vertical surgical device competitor with global distribution.
  • Stryker: Large diversified surgical and medical device incumbent with hospital sales coverage that overlaps Corza's surgical-center and operating-room footprint, particularly in instruments and surgical adjacencies.
  • Boston Scientific: Diversified medical device incumbent with procedural and surgical adjacencies; relevant for benchmarking a multi-vertical surgical device business with global hospital coverage.
  • Abbott: Large diversified medtech incumbent with hospital channel reach and adjacent device franchises; useful as a benchmark for size, channel power, and global manufacturing footprint comparable to Corza's.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks6 records

Key highlights7 records

Customer concentration

Angiotech Pharmaceuticals social profiles

Digital presence

Angiotech Pharmaceuticals financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Angiotech Pharmaceuticals leadership team

Management profile

Number of profiles

Profiles1 record

Angiotech Pharmaceuticals subsidiaries and ownership

Company hierarchy

Subsidiaries1 record

Angiotech Pharmaceuticals funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors8 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Angiotech Pharmaceuticals M&A and investment

M&A and investment

M&A3 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Angiotech Pharmaceuticals

What does Angiotech Pharmaceuticals do?

Angiotech's medical technology business, now operating as Corza Medical, manufactures and sells surgical medical devices across four product verticals: Biosurgery (TachoSil hemostatic sealants), Biomedical Textiles (Pearsalls OEM textiles), Ophthalmology (Katena instruments, SensorTek ROP Kit, Onatec sutures), and Wound Closure (Quill barbed sutures, Express Gut, Sharpoint sutures). Products are sold to hospitals, surgical centers, ophthalmology practices, and individual healthcare professionals via direct field sales, e-commerce stores, and a digital customer portal in 80+ countries.

Is Angiotech Pharmaceuticals a public or private company?

Angiotech Pharmaceuticals is a private company. It is classified as private equity controlled and is currently operating.

When was Angiotech Pharmaceuticals founded?

Angiotech Pharmaceuticals was founded in 1975. It employs 1,001 to 5,000 people.

Where is Angiotech Pharmaceuticals based?

Angiotech Pharmaceuticals is headquartered in Vancouver, Canada, in the North America region.

How does Angiotech Pharmaceuticals make money?

One revenue line is on record: medical Device Sales.

Who are Angiotech Pharmaceuticals's main competitors?

Direct peers on record are Ethicon (Johnson & Johnson MedTech), Becton, Dickinson and Company (BD), Smith+Nephew, Integra LifeSciences, CONMED and BVI Medical (Beaver-Visitec International). Broad incumbents are Medtronic, Stryker, Boston Scientific and Abbott.

Does Angiotech Pharmaceuticals have an API?

No public API is recorded for Angiotech Pharmaceuticals.

What industry is Angiotech Pharmaceuticals in?

Angiotech Pharmaceuticals's product category is Surgical Medical Devices. Its primary akta.pro industry code is HLAHADAL, Surgical Stapling, Suturing & Hemostasis (Staplers, Clips, Sealants, Tourniquets), with a secondary code of HLAHADAA, Open & Minimally Invasive Surgical Instruments (Handheld, Laparoscopic, MIS). Its NAICS code is 339112 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireCaliber Ophthalmics abre novo centro de excelência em oftalmologia de última geraçãoCaliber Ophthalmics, a unit of Surgical Specialties Corporation, announced the opening of a new ophthalmic product development and manufacturing excellence center in Sinking Spring, Pennsylvania. The 2,137 square meter facility includes a medical device clean room, an engineering development center, and advanced blade manufacturing capabilities, and received ISO 13485 certification in December 2020. The new center combines teams from the previously acquired Unique Technologies Inc. (UTI) and VPM Surgical Inc. to expand capacity and reduce lead times for global customers.PR NewswireCaliber Ophthalmics abre un nuevo Centro de Excelencia en Oftalmología de vanguardiaCaliber Ophthalmics, a unit of Surgical Specialties Corporation, opened a new Center of Excellence for ophthalmic design and manufacturing in Sinking Spring, Pennsylvania. The 23,000-square-foot facility combines teams from previously acquired companies Unique Technologies Inc. and VPM Surgical Inc., and received ISO 13485 certification in December 2020. The company stated the new facility will increase capacity and reduce lead times for global customers.PR NewswireSurgical Specialties Corporation lance la division Caliber Ophtalmics pour se concentrer sur la croissance mondiale des procédures chirurgicales ophtalmiquesSurgical Specialties Corporation (SSC) launched Caliber Ophthalmics, a new commercial division combining its Sharpoint™ brand with two recent acquisitions, Unique Technologies and VPM Surgical, to expand its ophthalmic surgical products globally. SSC appointed Yong Sun, an experienced medical device executive, to lead the new division, which will be supported by a planned ophthalmology manufacturing and engineering center of excellence in Pennsylvania. The company cited an industry inflection point driven by global economic expansion, aging populations, and rapid growth in eye surgeries as the catalyst for this strategic reorganization.FinSMEsAngiotech Pharmaceuticals Closes Financing Round of Undisclosed AmountAngiotech Pharmaceuticals closed an undisclosed financing round led by Vivo Capital and ZQ Capital, with participation from several investors. The Vancouver-based medical device company, which has over 2,000 employees and sells to customers in over 80 countries, did not disclose the terms.PR NewswireVivo Capital and ZQ Capital Limited enter into an Agreement to Acquire Angiotech PharmaceuticalsAngiotech Pharmaceuticals announced a definitive agreement to be acquired by a group of investors led by Vivo Capital LLC and ZQ Capital Limited. The investment syndicate aims to acquire 100% of Angiotech's shares, with the transaction expected to close in the first quarter of 2017. This move is seen as a strategic fit for further growth in Angiotech's core markets.PR NewswireSurgical Specialties Corporation Announces Approval of Expanded Use for BioSentry™ Track Sealant System in EuropeSurgical Specialties Corporation received expanded European CE Mark approval for its BioSentry™ Track Sealant System, enabling use with larger 17 gauge biopsy systems in addition to the existing 19 gauge compatibility. The device, which delivers a hydrogel plug along the biopsy needle tract to prevent pneumothorax, demonstrated in a 339-patient randomized trial a greater than 50% relative risk reduction in pneumothorax occurrence and significant reductions in chest tube placements, additional radiographs, and post-procedure admissions. The company stated this approval positions BioSentry™ to become the standard of care for post-lung biopsy procedures across Europe.GlobeNewswireDelisting of Securities of Molecular Insight Pharmaceuticals, Inc., Helicos BioSciences Corporation, China INSOnline Corp., Media Sciences International Inc., Angiotech Pharmaceuticals, Inc., and ICOPNASDAQ announced delisting of six companies—Molecular Insight, Helicos, China INSOnline, Media Sciences, Angiotech, and ICOP Digital—whose stocks had been suspended and not traded since specific dates. NASDAQ will file Form 25 with the SEC, and delistings take effect ten days after filing.